ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Inc (ENTA)

6.28
0.42
(7.17%)
Closed 23 December 8:00AM
6.28
-0.03
(-0.48%)
After Hours: 11:33AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 23.59M17.8M18.89M18.93M18M17.05M17.97M14.61M
Operating Income -30.01M-39.45M-36.71M-31.03M-34.89M-32.77M-24.19M-29.85M
Pre Tax Income -29.02M-37.61M-34.84M-29.52M-34.03M-31.52M-23.05M-29.19M
Net Income -28.99M-37.66M-39.07M-28.11M-33.41M-31.16M-22.66M-28.82M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -30.01M-39.45M-36.71M-31.03M-34.89M-32.77M-24.19M-29.78M
EBITDA -29.5M-38.91M-36.06M-30.36M-34.24M-32.15M-23.59M-29.38M
Year End 30 September 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 102.81M206.63M205.2M122.47M97.07M86.16M79.2M67.64M
Operating Income 24.61M88.33M36.74M-41.64M-109.57M-123.84M-137.21M-121.69M
Pre Tax Income 26.95M93.12M45.56M-35.02M-107.58M-122.19M-131M-117.79M
Net Income 17.71M71.96M46.38M-36.17M-79M-121.76M-133.82M-116.05M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.9263.712.354-1.801-3.903-5.876-6.356-5.477
EBIT 24.61M88.33M36.74M-41.64M-109.57M-123.84M-137.21M-121.62M
EBITDA 26.75M90.85M40M-38M-106.24M-120.87M-134.84M-119.36M

Your Recent History

Delayed Upgrade Clock